Richard A. Zordani Jr., Director at GALECTIN THERAPEUTICS INC (GALT), bought 5,000 shares at $2.02 ($10K) on 2022-01-14, disclosed to the SEC on 2022-01-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| GALT | BUY | 2024-04-30 | $4K | — | Filing → |
| GALT | BUY | 2022-07-29 | $13K | — | Filing → |
| GALT | BUY | 2022-04-04 | $8K | — | Filing → |